FDA Vaccine Chief’s Tumultuous Tenure Ends Amid Growing Industry and Public Frustration
Dr. Vinay Prasad’s second abrupt exit from the FDA underscores ongoing turmoil within an agency struggling under conflicting pressures between innovation and overregulation—raising serious questions about America’s ability to secure timely, effective medical protections.
In a stark reminder of the chaos inflaming federal regulatory agencies, Dr. Vinay Prasad, the Food and Drug Administration’s (FDA) embattled vaccine and biotech chief, is leaving the agency for the second time in less than a year. His departure signals continuing instability at a critical moment when America needs robust, efficient approval processes to maintain its health security and economic vitality. Why does this matter for American families and national sovereignty? Under Dr. Prasad’s watch, the FDA has repeatedly flipped on crucial vaccination reviews and gene therapy approvals—delaying life-saving treatments while sowing confusion among pharmaceutical innovators who are vital...
This is Exclusive Content for Subscribers
Join our community of patriots to read the full story and get access to all our exclusive analysis.
View Subscription Plans